Physician profile
Nicolas W Shammas
NPI 1922087857
$808,015.70
in general payments reported to CMS, 2019-2025
50 companies · $56K in 2025
The $56K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $222K · 2020: $129K · 2021: $107K · 2022: $123K · 2023: $122K · 2024: $48K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $176K · Travel and Lodging: $23K · Consulting Fee: $16K · Food and Beverage: $6,446 · Honoraria: $5,200 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $175,681.00 |
| Travel and Lodging | $22,884.48 |
| Consulting Fee | $15,515.98 |
| Food and Beverage | $6,445.78 |
| Honoraria | $5,200.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $189,493.78 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130,214.41 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $92,093.68 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $85,037.94 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $59,851.29 | 2022-2023 | Verquvo |
| Amgen INC. | $42,439.73 | 2020-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $33,769.69 | 2019 | |
| Esperion Therapeutics, INC. | $29,287.26 | 2020-2021 | |
| Venturemed Group, INC. | $26,268.61 | 2019-2022 | |
| Boston Scientific Corporation | $22,907.84 | 2019-2025 | Eluvia, Jetstream Sc |
| Abbott Laboratories | $17,678.06 | 2019-2025 | Omnilink Elite, Esprit, Diamondback Peripheral |
| Angiodynamics, INC. | $16,877.53 | 2019-2025 | Auryon Laser System 100-120 Vac, Angiovac, Alphavac |
| Bard Peripheral Vascular, INC. | $10,559.64 | 2019-2023 | Rotarexs 6 F X 135 Cm |
| Philips North America LLC | $8,643.97 | 2019-2021 | |
| Intact Vascular, INC. | $8,500.75 | 2019 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8,415.94 | 2019-2024 | Lifevest |
| Kiniksa Pharmaceuticals, Ltd. | $7,221.69 | 2021-2022 | |
| Shockwave Medical, INC | $6,438.54 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $5,220.18 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $1,214.76 | 2020-2023 | Brilinta |
| Provisio Medical, INC. | $1,200.00 | 2022 | |
| Medtronic Vascular, INC. | $1,042.46 | 2019 | |
| Cook Medical LLC | $563.79 | 2019-2025 | Zenith Spiral-Z, Zilver Ptx, Rosen |
| Cook Incorporated | $540.00 | 2021 | |
| Inari Medical, INC. | $423.88 | 2020 | |
| Medtronic, INC. | $307.77 | 2022-2023 | |
| Lantheus Medical Imaging, INC. | $222.98 | 2019-2023 | Definity |
| Endologix LLC | $206.27 | 2019 | |
| Novo Nordisk INC | $164.24 | 2021-2024 | Wegovy, Ozempic |
| Becton, Dickinson and Company | $154.17 | 2024 | Venovo, Lutonix Drug Coated Balloon |
| Lexicon Pharmaceuticals, INC. | $137.57 | 2023-2024 | Inpefa |
| Astellas Pharma US INC | $131.99 | 2020 | |
| Abiomed | $119.91 | 2019-2020 | |
| Ablative Solutions, INC. | $109.75 | 2022 | |
| Reflow Medical INC | $97.70 | 2023 | |
| Chiesi USA, INC. | $92.22 | 2021 | |
| Vesper Medical | $81.10 | 2021 | |
| Amplitude Vascular Systems, INC. | $75.35 | 2024 | |
| Pfizer INC. | $69.38 | 2024 | |
| Biosense Webster, INC. | $44.08 | 2019-2021 | |
| Cardiva Medical, INC. | $20.83 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Mannkind Corporation | $19.65 | 2023 | Afrezza |
| Cvrx, INC. | $18.15 | 2025 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $17.96 | 2022 | |
| Smith+Nephew, INC. | $17.00 | 2019 | |
| Penumbra, INC. | $2.21 | 2021 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$250,519.39 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicolas Shammas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.